For example, O’Dell and colleagues demonstrated that mutant Kras expression alone led to ICC development with low penetrance and after a long latency, while the combination of mutant Kras expression and TP53 deletion resulted in near-complete penetrance of ICC development, often with evidence of metastatic disease, in addition to HCC development [40]. This evidence concerns the gene KRAS and intrahepatic cholangiocarcinoma.